My PCR
Create Account
Logo PCR

11 Sep 2025

Tricuspid / Pulmonary valve

Minimalist approach to tricuspid valve therapy

Sponsored by P&F Products & Features

Anchorperson: C. Guedes Bezerra
Spokesperson: A. Ferrero Guadagnoli
SHOW MORE

Summary

This session highlights the minimalist approach to tricuspid valve therapy with TricValve implantation, a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Clinical evidence shows reduced hospitalisations, improved quality of life, and encouraging mid-term outcomes, including smaller right heart chamber dimensions and reduced reverse flow.

Learning Objectives

  • To demonstrate, through a TricValve implantation, how tricuspid regurgitation can be treated using a minimally invasive, contrast-free procedure guided by transthoracic echo (TTE) and requiring minimal fluoroscopy time—resulting in a safe and effective outcome for the patient
  • To present TricValve clinical evidence from a self-controlled study showing a reduction in hospitalisation rates and improved quality of life in patients with tricuspid regurgitation
  • To highlight mid-term study data showing a reduction in right heart chamber dimensions following TricValve implantation, with significant decrease in reverse flow to the vena cava and improvement in right ventricular pressure
Related Content
How will the new valvular guidelines impact my tricuspid programme? Tricuspid, mitral and structural innovations Retrievals, foreign bodies and entrapments
Recommended for you
Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines Join #PCRLV - Register now! Take the stage at EuroPCR